期刊文献+

过量奥卡西平致定向力障碍及共济失调 被引量:3

Disorientation and ataxia following an overdose of oxcarbazepine
原文传递
导出
摘要 1例6岁男性癫痫患儿,曾先后口服苯妥英钠、拉莫三嗪、丙戊酸钠、苯巴比妥治疗,因不能规律服药致使癫痫反复发作且进行性加重,家属自行给予其口服奥卡西平300 mg、3次/d,上述症状未再发作。但40 d后出现行走不稳、反应迟钝,且癫痫症状也加重。入院诊断为癫痫,全身强直-阵挛发作,奥卡西平致定向力障碍及共济失调。停用奥卡西平,给予丙戊酸钠、还原性谷胱甘肽、维生素C,次日癫痫得到控制。第8天定向力障碍及共济失调消失,癫痫未再发作,遂出院。出院后规律服用丙戊酸钠和氯硝西泮。随访1个月,未再出现癫痫发作、定向力障碍和共济失调。 A 6-year-old male child with epilepsy had received oral phenytoin sodium, lamotrigine, sodium valproate, and phenobarbital. Because of his irregular use of the drugs, he developed repeated epileptic seizures which progressively worsened. His parents gave him oral oxcarbazepine 300 mg thrice daily themselves and the above-mentioned symptoms did not reappear. However, 40 days later, he experienced unstable walking and torpid response, and his epilepsy symptoms became aggravated. The patient was diagnosed with epilepsy, generalized tonic-clonic seizure, oxcarbazepine-induced disorientation, and ataxia on admission. Oxcarbazepine was stopped, and sodium valproate, reduced glutathione, and vitamin C were given. The next day, his epilepsy symptoms were controlled and, on day 8, his disorientation and ataxia resolved. So he was discharged. He received regularly sodium valproate and clonazepam after discharge and epilepsy seizure, disorientation, and ataxia did not recur at one-month follow-up.
出处 《药物不良反应杂志》 2012年第3期170-171,共2页 Adverse Drug Reactions Journal
关键词 癫痫 定向力 共济失调 奥卡西平 定向力障碍 epilepsy orientation ataxia oxcarbazepine disorientation
  • 相关文献

参考文献3

二级参考文献43

  • 1王湘庆,郎森阳.新型抗癫痫药物对认知功能的影响[J].海军总医院学报,2006,19(1):26-29. 被引量:7
  • 2江帆.美国的奥卡西平说明书中增加新的警告[J].中国药师,2006,9(6):571-571. 被引量:4
  • 3Raju GP,Sarco DP, Poduri A. Oxcarbazepine in children with nocturnal frontal - lobe epilepsy[J]. Pediatr Neurol, 2007,37 ( 5 ) :345 - 349. 被引量:1
  • 4Schdeo R, Beydaun A, Schachter S, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures [ J ]. Neurology, 2001,57 (5) :864 -871. 被引量:1
  • 5Coppola G,Franzoni E,Verrotti A,et al. Levetiracetam or oxearbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes ( BECTS ) : An open - label, parallel group trial [J]. Brain Dev,2007,29(5 ) :281 - 284. 被引量:1
  • 6Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group[ J]. Neurology,2000,54(12) :2237 -2244. 被引量:1
  • 7Bares G, Walkcr EB, Elger CE,et al. Oxcarbazepine placebo -controlled, dose - ranging trial in refractory partial epilepsy [ J ]. Epilepsia, 2000,41 (12) :1597 - 1607. 被引量:1
  • 8Tutor - Crespo M J, Hermida J, Tutor JC. Relation of blood platelet count during carbamazepine and oxcarbazepine treatment with daily dose, and serum concentrations of carbamazepine, carbamazepine - 10,11 - epoxide, and 10 - hydroxycarbazepine [ J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub ,2007,151 (1) :91 -94. 被引量:1
  • 9Pauletto G, Bergonzi P, Triveneto Epilepsy Study Group. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice [ J ]. Seizure,2006,15 ( 3 ) : 150 - 155. 被引量:1
  • 10Bourgeois BF,D'Souza J. Long term safty and toleradility of oxcarbazepine in children:A rewiew of clinical experience [J]. Epilepsy Behav, 2005,7 ( 3 ) :375 - 382. 被引量:1

共引文献48

同被引文献75

  • 1喻东山.奥卡西平临床应用的安全性[J].药物不良反应杂志,2007,9(2):105-107. 被引量:20
  • 2张丽,周权.奥卡西平致严重药疹反应1例[J].天津药学,2007,19(5):34-34. 被引量:3
  • 3Kalis MM, Huff NA. Oxcarbazepine, an antiepileptic agent[J]. Clin Ther, 2001, 23(5): 680-700, 645. 被引量:1
  • 4Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?[J]. Epilepsy Behav, 2004, 5(5): 627-635. 被引量:1
  • 5He N, Min FL, Shi YW, et al. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles[J]. Seizure, 2012, 21(8): 614-618. 被引量:1
  • 6Chung WH, Hung SI, Chen YT. Genetic predisposition of lifethreatening antiepileptic-induced skin reactions[J]. Expert Opin Drug Saf, 2010, 9(1): 15-21. 被引量:1
  • 7Hung SI, Chung WH, Chen YT. HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine[J]. Personal Med, 2005, 2(3): 225-237. 被引量:1
  • 8Le Louet H, Thomas L, Babai S. DRESS: is oxcarbazepine safer than carbamazepine? An analysis of the French Pharmacovigilance database[J]. Eur J Neurol, 2008, 15(5): e43. 被引量:1
  • 9Knudsen JF, Flowers CM, Kortepeter C, et al. Clinical profile of oxcarbazepine-related angioneurotic edema: case report and review[J]. Pediatr Neurol, 2007, 37(2): 134-137. 被引量:1
  • 10Bourgeois BF, D'Souza J. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience[J]. Epilepsy Behav, 2005, 7(3): 375-382. 被引量:1

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部